Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.

Authors not listed

University Hospital, Strasbourg, France · 2012

Abstract

The aim of the protocol is to study the resting brain activation profile of 3 groups of people, using a new fMRI procedure, called fMRI-SAM. fMRI-SAM will be applied to 25 Alzheimer's disease (AD) patients, 25 patients suffering from amnestic - mild cognitive impairment (MCI) - a clinical picture which may be a prodromal form of AD - and 60 healthy controls. The first analysis of the data will search differences of brain activation profiles between the 3 groups. In the second step, the investigators will study the predictive value of fMRI-SAM to detect MCI patients who will later convert to AD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2012). Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease. <em>University Hospital, Strasbourg, France</em>. https://clinicaltrials.gov/study/NCT00412048
Vancouver
Anonymous. Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease. University Hospital, Strasbourg, France. 2012.
BibTeX
@misc{anon2012Evalua, title = {Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.}, author = {Anonymous}, journal = {University Hospital, Strasbourg, France}, year = {2012}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings